Semaglutide patent expiry opens over Rs 50,000 Crore opportunity

In India, the launch of generic semaglutide, expected in the first quarter of FY27, is projected to boost overall...

Samsung Biologics secures half of Japan’s top 10 pharmas

Samsung Biologics Co is accelerating its expansion in Japan, the world's third-largest pharmaceutical market. The...

Vaishali Pharma’s H1 FY24 Revenue Up By 9%

Mumbai (Maharashtra) [India], November 9: Vaishali Pharma Limited (NSE - VAISHALI), engaged in production and...

JB Pharma records revenue growth of 32 per cent

Mumbai (Maharashtra) [India], February 11 (ANI/PNN): JB Pharma, one of the fastest-growing pharmaceutical companies...

Sun Pharma shares dip after disappointing Q4 results

Mumbai (Maharashtra) [India], May 31 (ANI): Share price of Sun Pharmaceutical Industries slumped by around four per...

Sun Pharma posts Rs 2,227 crore net loss in Q4 of 2021-22

Mumbai (Maharashtra) [India], May 30 (ANI): Sun Pharmaceuticals Industries on Monday reported a consolidated net...